You are here: Industry Insights > Qilu

News List

Qilu Pharmaceutical Achieved Staggering Sales of Bevacizumab of RMB1.8 Billion in 2020 PharmaSources/Caicai
March 04, 2021
According to industry news, Qilu Pharmaceutical achieved sales of bevacizumab (trade name: Ankeda) of about RMB1.8 billion in 2020.
Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner PharmaSources
September 18, 2024
Cordlife unveiled its enhanced processing and storage facility, featuring strengthened operational protocols and an advanced laboratory monitoring system, among other improvements.
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC prnasia
April 19, 2021
Peptron, Inc., a South Korea-based biotech company, and Qilu Pharmaceutical, a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative medicines announced that the companies ...